Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iain MacPhee

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Nephrology|December 19, 2006
Proteinuria in 3 sequential pregnancies following a fourth renal transplantKate Wiles, Nasirul Ekbal, Ekbal Nasirul, et al.
Kidney International Reports|November 22, 2021
Design of FLAIR: a Phase 2b Study of the 5-Lipoxygenase Activating Protein Inhibitor AZD5718 in Patients With Proteinuric CKDHiddo J L Heerspink, Gordon Law, Konstantina Psachoulia, et al.
British Journal of Clinical Pharmacology|June 3, 2024
A drug-drug interaction study and physiologically based pharmacokinetic modelling to assess the effect of an oral 5-lipoxygenase activating protein inhibitor on the pharmacokinetics of oral midazolamJane Knöchel, Vijender Panduga, Karin Nelander, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 24, 2011
Dose-finding study of peginesatide for anemia correction in chronic kidney disease patientsIain C Macdougall, Andrzej Wiecek, Beatriz Tucker, et al.
Molecular and Cellular Endocrinology|February 11, 2018
Steroid regulation: An overlooked aspect of tolerance and chronic rejection in kidney transplantationSofia Christakoudi, Manohursingh Runglall, Paula Mobillo, et al.
Ebiomedicine|July 25, 2020
Development and validation of the first consensus gene-expression signature of operational tolerance in kidney transplantation, incorporating adjustment for immunosuppressive drug therapySofia Christakoudi, Manohursingh Runglall, Paula Mobillo, et al.
Therapeutic Drug Monitoring|May 3, 2019
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus ReportMercè Brunet, Teun van Gelder, Anders Åsberg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 3, 2018
Long- and short-term outcomes in renal allografts with deceased donors: A large recipient and donor genome-wide association studyMaria P Hernandez-Fuentes, Christopher Franklin, Irene Rebollo-Mesa, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Nephrology|December 19, 2006
Proteinuria in 3 sequential pregnancies following a fourth renal transplantKate Wiles, Nasirul Ekbal, Ekbal Nasirul, et al.
Kidney International Reports|November 22, 2021
Design of FLAIR: a Phase 2b Study of the 5-Lipoxygenase Activating Protein Inhibitor AZD5718 in Patients With Proteinuric CKDHiddo J L Heerspink, Gordon Law, Konstantina Psachoulia, et al.
British Journal of Clinical Pharmacology|June 3, 2024
A drug-drug interaction study and physiologically based pharmacokinetic modelling to assess the effect of an oral 5-lipoxygenase activating protein inhibitor on the pharmacokinetics of oral midazolamJane Knöchel, Vijender Panduga, Karin Nelander, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 24, 2011
Dose-finding study of peginesatide for anemia correction in chronic kidney disease patientsIain C Macdougall, Andrzej Wiecek, Beatriz Tucker, et al.
Molecular and Cellular Endocrinology|February 11, 2018
Steroid regulation: An overlooked aspect of tolerance and chronic rejection in kidney transplantationSofia Christakoudi, Manohursingh Runglall, Paula Mobillo, et al.
Ebiomedicine|July 25, 2020
Development and validation of the first consensus gene-expression signature of operational tolerance in kidney transplantation, incorporating adjustment for immunosuppressive drug therapySofia Christakoudi, Manohursingh Runglall, Paula Mobillo, et al.
Therapeutic Drug Monitoring|May 3, 2019
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus ReportMercè Brunet, Teun van Gelder, Anders Åsberg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 3, 2018
Long- and short-term outcomes in renal allografts with deceased donors: A large recipient and donor genome-wide association studyMaria P Hernandez-Fuentes, Christopher Franklin, Irene Rebollo-Mesa, et al.
Pageof 2